|
|
Volumn 90, Issue 9, 2011, Pages 1115-1116
|
|
Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BORTEZOMIB;
DEXAMETHASONE;
DOXORUBICIN;
LENALIDOMIDE;
ADULT;
AGED;
ANEMIA;
CANCER GROWTH;
CANCER RELAPSE;
CANCER RESISTANCE;
CANCER STAGING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FATIGUE;
FEMALE;
HUMAN;
INFECTION;
LETTER;
MALE;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
NEUROPATHY;
NEUTROPENIA;
OUTCOME ASSESSMENT;
PAIN;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CHEMOTHERAPY, ADJUVANT;
DEXAMETHASONE;
DOXORUBICIN;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MITOXANTRONE;
MULTIPLE MYELOMA;
POLYETHYLENE GLYCOLS;
PYRAZINES;
RETROSPECTIVE STUDIES;
THALIDOMIDE;
TREATMENT OUTCOME;
VINCRISTINE;
|
|
EID: 80052387015
PISSN: 09395555
EISSN: 14320584
Source Type: Journal
DOI: 10.1007/s00277-010-1136-5 Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
